Market Overview:
Cardiovascular Optical Coherence Tomography (OCT) systems are advanced imaging tools that use light waves to capture high-resolution, cross-sectional images of the blood vessels, heart, and other tissues within the cardiovascular system. OCT is a non-invasive, non-ionizing imaging modality that provides detailed information about the structure and function of cardiovascular tissues, primarily focusing on the coronary arteries.
Manufacturers are introducing next-generation OCT catheters with faster pullback speeds, improved resolution, and AI-assisted imaging to enhance PCI outcomes. For instance, in October 2024, Gentuity, LLC announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its Gentuity HF-OCT Imaging System, featuring the Vis-Rx Micro-Imaging Catheter, for use both before and after percutaneous coronary intervention (PCI), making it the only intravascular imaging platform specifically indicated for the assessment of the coronary vessel pre and post intervention.
Advanced OCT software in cardiovascular imaging integrates Artificial Intelligence (AI) and Machine Learning (ML) to automate image analysis, enabling precise assessments and informed decision-making during percutaneous coronary interventions (PCI). Thus, the major market players are focusing on the OCT software with artificial intelligence (AI) for various advantages.
For instance, in October 2023, Abbott launched Ultreon 1.0, a coronary imaging software in India. This software merges optical coherence tomography (OCT) with artificial intelligence (AI), providing physicians with a view of blood flow and blockages within coronary arteries. The software can differentiate between calcified and noncalcified blockages, detect the severity of calcium-based blockages, and measure vessel diameter. It also aids physicians in guiding stent deployment and ensuring optimal stent expansion.
Market Size Growth Rate:
According to the DataM market research report, the global cardiovascular optical coherence tomography (OCT) systems market size is valued at USD 612.20 million in 2024 and is expected to reach USD 1,034.99 million by 2032, with growth at a CAGR of 6.8% over the forecast period of 2025-2032.
Executive Summary:
Market Segmentation:
By Product Type:
- OCT Catheters
- OCT Devices
- OCT Software
- Services
By End User:
- Hospitals
- Ambulatory Surgical Centers
- CATH Labs
- Others
By Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Recent Developments in the Industry:
- In October 2024, Gentuity, LLC announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its Gentuity HF-OCT Imaging System, featuring the Vis-Rx Micro-Imaging Catheter, for use both before and after percutaneous coronary intervention (PCI), making it the only intravascular imaging platform specifically indicated for the assessment of the coronary vessel pre and post intervention.
- In October 2023, Abbott launched Ultreon 1.0, a coronary imaging software in India. This software merges optical coherence tomography (OCT) with artificial intelligence (AI), providing physicians with a view of blood flow and blockages within coronary arteries. The software can differentiate between calcified and noncalcified blockages, detect the severity of calcium-based blockages, and measure vessel diameter. It also aids physicians in guiding stent deployment and ensuring optimal stent expansion.
Major Players:
The major companies in the global cardiovascular optical coherence tomography (OCT) systems market include TERUMO CORPORATION, Nipro, and Abbott, among others.
The Full Report has the following insights:
- The report offers a comprehensive evaluation of the market in terms of market value (US$) and Y-o-Y Growth Rates (%). It does so via in-depth qualitative insights, historical data, and verifiable projections about market size during the forecast period (2025-2032).
- Visualize the composition of the global cardiovascular optical coherence tomography (OCT) systems market segmentation by product type, end user, and region, highlighting the key commercial assets and players.
- By Product Type: OCT Catheters, OCT Devices, OCT Software, and Services.
- By End-User: Hospitals, Ambulatory Surgical Centers, CATH Labs, and Others.
- By Region: North America, Europe, Asia Pacific, South America, Middle East & Africa.
- Identify commercial opportunities in the global cardiovascular optical coherence tomography (OCT) systems market by analyzing trends and co-development deals.
- The report also covers data insights on various industry forces, such as Porter's five forces analysis, supply chain analysis, latest developments and breakthroughs, swot analysis, unmet needs and gaps, and recommended strategies for market entry and expansion.
- PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
- Product mapping in Excel for the key products of all major market players
- The report will provide access to approximately 50+ market data tables, 40+ figures, and close to 179 pages.
